Alpha tau medical ltd.DRTSW.US Overview

US StockHealthcare

(No presentation for DRTSW)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock SentimentalTradingView Chart

DRTSW Overall Performance

DRTSW AI Analysis & Strategy

DRTSW Recent Performance

3.89%

Alpha tau medical ltd.

0.81%

Avg of Sector

-1.14%

S&P500

DRTSW PowerScanner

DRTSW Key Information

DRTSW Valuation Metrics

DRTSW Earnings Table

DRTSW Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.